Now we just need a decent reporter like jason gale bloomberg to put this together with the info unfolding in Japan - it's pretty compelling info that -i assume should be affecting every stockpiling decision around the world. All ears for a gsk production ungrade my guess is the first announcement will be from the existing 190m doses/annumn to around 250m which is about their max capacity from bulk powder at the moment. from there next target would have to be at least 400m to make up the shortfall in tamiflu as the resistance unfolds further ... any other rational guesses?
BTA Price at posting:
$2.31 Sentiment: LT Buy Disclosure: Held
